Svante Vikingsson

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays

Circumstances, postmortem findings, blood concentrations and metabolism in a series of methoxyacetylfentanyl-related deaths

Post-mortem metabolomics: A novel approach in clinical biomarker discovery and a potential tool in death investigations

Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism

Activation of the μ‐opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure

In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects

Structure Elucidation of Urinary Metabolites of Fentanyl and Five Fentanyl Analogs using LC-QTOF-MS, Hepatocyte Incubations and Synthesized Reference Standards

Metabolism of MMB022 and identification of dihydrodiol formation in vitro using synthesized standards

The influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell line

Metabolite profiling of ortho-, meta- and para-fluorofentanyl by hepatocytes and high-resolution mass spectrometry

Femoral blood concentrations of flualprazolam in 33 postmortem cases

Metabolism of the benzodiazepines norflurazepam, flurazepam, fludiazepam and cinolazepam by human hepatocytes using high-resolution mass spectrometry and distinguishing their intake in authentic urine samples

5F-MDMB-PICA metabolite identification and cannabinoid receptor activity

Biotransformation of the new synthetic cannabinoid with an alkene, MDMB-4en-PINACA, by human hepatocytes, human liver microsomes, and human urine and blood

LC-QTOF-MS identification of major urinary cyclopropylfentanyl metabolites using synthesized standards

Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients

Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-

Metabolism study for CUMYL-4CN-BINACA in human hepatocytes and authentic urine specimens: Free cyanide is formed during the main metabolic pathway

A reassessment of DNA-immunoprecipitation-based genomic profiling

Synthesis and identifications of potential metabolites as biomarkers of the synthetic cannabinoid AKB-48